The Library
Induction of immunogenic cell death in cancer cells by a photoactivated platinum(iv) prodrug
Tools
Tools
Tools
Novohradsky, Vojtech, Pracharova, Jitka, Kasparkova, Jana, Imberti, Cinzia, Bridgewater, Hannah E., Sadler, Peter J. and Brabec, Viktor (2020) Induction of immunogenic cell death in cancer cells by a photoactivated platinum(iv) prodrug. Inorganic Chemistry Frontiers, 7 (21). pp. 4150-4159. doi:10.1039/d0qi00991a ISSN 2052-1553.
|
PDF
WRAP-induction-immunogenic-cell-death-cancer-cells-photoactivated-platinum(iv)-prodrug-Sadler-2020 .pdf - Accepted Version - Requires a PDF viewer. Download (1593Kb) | Preview |
Official URL: http://dx.doi.org/10.1039/d0qi00991a
Abstract
The platinum(IV) prodrug trans,trans,trans-[Pt(N3)2(OH)2(py)2] (1) is stable and non-toxic in the dark, but potently cytotoxic to cancer cells when irradiated by visible light, including cisplatin-resistant cells. On irradiation with visible light, it generates reactive Pt(II) species which can attack DNA, and produces reactive oxygen species (ROS) and reactive nitrogen species (RNS) which exert unusual effects on biochemical pathways. We now show that its novel mechanism of action includes induction of immunogenic cell death (ICD). Treatment of cancer cells with 1 followed by photoirradiation with visible light induces calreticulin (CRT) expression at the surface of dying cancer cells. This is accompanied by release of high mobility group protein-1B (HMGB1) and the secretion of ATP. Autophagy appears to play a key role in this chemotherapeutically-stimulated ICD. The observed uneven distribution of ecto-CRT promotes phagocytosis, confirmed by the observation of engulfment of photoirradiated CT26 colorectal cancer cells treated with 1 by J774.A1 macrophages. The photoactivatable prodrug 1 has a unique mechanism of action which distinguishes it from other platinum drugs due to its immunomodulating properties, which may enhance its anticancer efficacy.
| Item Type: | Journal Article | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Subjects: | Q Science > QC Physics R Medicine > RC Internal medicine R Medicine > RM Therapeutics. Pharmacology |
||||||||||||||||||
| Divisions: | Faculty of Science, Engineering and Medicine > Science > Chemistry | ||||||||||||||||||
| Library of Congress Subject Headings (LCSH): | Cancer cells , Cancer cells -- Effect of radiation on, Cancer cells -- Effect of drugs on, Prodrugs , Platinum -- Therapeutic use, Irradiation | ||||||||||||||||||
| Journal or Publication Title: | Inorganic Chemistry Frontiers | ||||||||||||||||||
| Publisher: | RSC | ||||||||||||||||||
| ISSN: | 2052-1553 | ||||||||||||||||||
| Official Date: | 18 September 2020 | ||||||||||||||||||
| Dates: |
|
||||||||||||||||||
| Volume: | 7 | ||||||||||||||||||
| Number: | 21 | ||||||||||||||||||
| Page Range: | pp. 4150-4159 | ||||||||||||||||||
| DOI: | 10.1039/d0qi00991a | ||||||||||||||||||
| Status: | Peer Reviewed | ||||||||||||||||||
| Publication Status: | Published | ||||||||||||||||||
| Access rights to Published version: | Restricted or Subscription Access | ||||||||||||||||||
| Date of first compliant deposit: | 25 May 2021 | ||||||||||||||||||
| Date of first compliant Open Access: | 18 September 2021 | ||||||||||||||||||
| RIOXX Funder/Project Grant: |
|
Request changes or add full text files to a record
Repository staff actions (login required)
 |
View Item |
Downloads
Downloads per month over past year
